How to Help Your Patients Find Doptelet in Stock: A Provider's Guide

When patients call your office frustrated that they can't find Doptelet (avatrombopag), having a clear, practiced response plan makes all the difference. This guide walks through every tool and pathway available to help your ITP and chronic liver disease (CLD) patients obtain Doptelet with minimal delay.

Why Doptelet Access Is a Clinical Issue, Not Just an Administrative One

For CLD patients, delayed access to Doptelet has direct procedural consequences. The 5-day treatment course must begin 10 to 13 days before a scheduled procedure, with a therapeutic window of 5 to 8 days post-last-dose for the procedure. Missing this window means rescheduling. For ITP patients, treatment gaps can lead to dangerously low platelet counts and increased bleeding risk.

Understanding and actively managing Doptelet access for your patients is therefore a clinical priority, not merely an administrative convenience.

Step 1: Use Doptelet Connect as Your Primary Routing Tool

Doptelet Connect (managed by AssistRx) is the manufacturer's hub for prescription routing, benefit investigation, PA support, and pharmacy assignment. Every Doptelet prescription for ITP or CLD should be submitted through this system. Key contact details:

Fax: 1-855-686-8729

Email: DopteletConnect@AssistRx.com

Escalation (reimbursement issues): Doptelet.escalation@sobi.com

Step 2: Consider In-Office Dispensing to Eliminate the Specialty Pharmacy Step

Physician practices can elect to become dispensing practices for Doptelet, stocking it in-house and dispensing directly to patients at the point of care. This is particularly valuable for hematology and hepatology practices where many patients are on Doptelet, as it eliminates the specialty pharmacy routing step and can significantly accelerate access.

If your practice is not currently set up for in-office dispensing, contact your Doptelet field representative or Doptelet Connect to learn about enrollment requirements.

Step 3: Document Thoroughly to Expedite Prior Authorization

The most common cause of PA delays is incomplete clinical documentation. Ensure your Doptelet PA submissions include:

Most recent platelet count (within 30 days) with dates

Confirmed diagnosis with ICD-10 codes (D69.3 for ITP; K74.60 or K74.69 for CLD)

Documentation of prior treatment failures (ITP: list previous therapies tried and responses)

For CLD: planned procedure name and date, as well as the intended Doptelet treatment dates

Letter of medical necessity signed by the attending provider

Step 4: Leverage medfinder to Find Available Dispensing Locations

When a patient's assigned specialty pharmacy experiences a delay or is unable to fill the prescription, medfinder for providers can help identify which specialty pharmacies in the Doptelet network currently have it in stock. This is particularly valuable for CLD patients where missing the procedure window is not an option.

Managing Patient Expectations: The Specialty Drug Access Timeline

Setting accurate patient expectations is an important part of the Doptelet prescribing workflow. When you initiate a Doptelet prescription, inform your patient of the following typical timeline:

Days 1-3: Enrollment form submitted, specialty pharmacy assigned, benefit investigation begins.

Days 3-21: Prior authorization review by insurer. Your office may receive requests for additional documentation.

After PA approval: Specialty pharmacy ships Doptelet to the patient (typically 1-3 business days).

Pediatric Patients: Special Considerations for Doptelet Sprinkle

For pediatric ITP patients aged 1 to less than 6 years, the FDA-approved formulation is Doptelet Sprinkle (avatrombopag oral granules), approved July 2025. The granules are sprinkled onto soft food or liquid — not swallowed as whole capsules. Ensure your prescription specifies Doptelet Sprinkle (not tablets) for this age group, and confirm the specialty pharmacy has the Sprinkle formulation in stock, as it may have separate inventory from the tablet form.

Summary Checklist: Doptelet Access Protocol for Your Practice

Always route through Doptelet Connect — never to a retail pharmacy

Submit complete PA documentation upfront — platelet counts, diagnosis codes, treatment history

For CLD patients: start the access process 5-6 weeks before procedure

Explore in-office dispensing — eliminate the specialty pharmacy routing step

Use medfinder — when your patient's pharmacy has a delay, quickly identify alternatives

For more background on the Doptelet access environment in 2026, see: Doptelet Shortage: What Providers and Prescribers Need to Know in 2026.